NasdaqCM - Delayed Quote USD
Renovaro Inc. (RENB)
0.3482
-0.0535
(-13.32%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-9,623.6520
-10,971.4300
-11,774.5490
-15,732.3360
-20,610.7230
Investing Cash Flow
-144.9700
-1,260.1790
-29.7740
-5.1560
-48.8920
Financing Cash Flow
9,727.9350
10,517.4550
4,515.0560
4,250.4640
32,601.5530
End Cash Position
203.2930
220.4670
1,874.4800
9,172.1420
20,664.4100
Income Tax Paid Supplemental Data
--
--
--
0.0340
0.0370
Interest Paid Supplemental Data
22.3080
20.1280
352.3340
79.7160
89.2240
Capital Expenditure
--
-70.4300
-29.7740
-5.1560
-48.8920
Issuance of Capital Stock
3,376.1810
3,000
4,011.8230
4,676.3990
33,066.1480
Issuance of Debt
7,227.5890
8,045.6630
--
--
1,221.3500
Repayment of Debt
--
-870.0730
-1,121.7670
-560.8480
-546.6510
Free Cash Flow
-9,652.4980
-11,041.8600
-11,804.3230
-15,737.4920
-20,659.6150
6/30/2021 - 2/7/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARMP Armata Pharmaceuticals, Inc.
1.3059
+5.31%
PEG.CO Pharma Equity Group A/S
0.0766
-8.15%
CLDI Calidi Biotherapeutics, Inc.
0.4690
+6.59%
ENTX Entera Bio Ltd.
1.9600
+6.52%
CMPX Compass Therapeutics, Inc.
1.9800
+11.24%
YMAB Y-mAbs Therapeutics, Inc.
4.2600
-11.62%
CLLS Cellectis S.A.
1.4400
+4.35%
BTAI BioXcel Therapeutics, Inc.
1.6800
-1.75%
LIPO Lipella Pharmaceuticals Inc.
2.3950
+5.51%
MEIP MEI Pharma, Inc.
1.9800
+3.66%